New York, NY · Founded 2019 · Privately Held (backing)
Developer of novel chemical entities designed to transform the treatment of psychiatric disorders through rapid-acting and durable therapies. Gilgamesh Pharma is based in New York, NY and was founded in 2019. Its last reported valuation was $189 million in May 2022. It has raised $136 million across 3 recorded rounds; the latest was a $2.3 million seed round in Mar 2026.
Last reported valuation
$188.5M
Oct 2026
Priced at
—
Total raised
$135.8M
Last round
Seed Round
Mar 2026
Team — not yet on record
No current team members for Gilgamesh Pharma are on record yet. People surface from round filings, company disclosures, and coverage sessions.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Gilgamesh Pharma with a free account
·The complete investor list: 24 names
·Watch Gilgamesh Pharma: the Monday email on marks, rounds and moves
